PRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Elaine Beller and colleagues from the PRISMA for Abstracts group provide a reporting guidelines for reporting abstracts of systematic reviews in journals and at conferences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) statement for reporting systematic reviews as recommended by the Cochrane Collaboration was used for this systematic review.”
From Systematic review and meta-analysis of the efficacy and safety of apixaban compared to rivaroxaban in acute VTE in the real world (2019) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The PRISMA extension checklist for abstracts was first introduced in 2013 and later updated in 2020.”
From Quality of Reporting Abstracts of Systematic Reviews and Meta-Analysis in Preventive Dentistry: An Assessment Using the PRISMA 2020 Extension (2026) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The difference between these two versions is new addition: PRISMA 2020 extension of the Abstracts checklist includes a new item 6 (synthesis of results), recommending authors to specify the methods used to present and synthesize results, which was not in the 2013 version.”
From Quality of Reporting Abstracts of Systematic Reviews and Meta-Analysis in Preventive Dentistry: An Assessment Using the PRISMA 2020 Extension (2026) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The PRISMA 2020 for Abstracts checklist retains the same items as those included in the PRISMA for Abstracts statement published in 201329 but has been revised to make the wording consistent with the PRISMA 2020 statement and includes a new item recommending authors specify the methods used to present and synthesize results (item #6).”
From PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews (2021) · cites this paper as [29]
The cited source says what the claim attributes to it.
In the citing paper
“An abstract providing key information about the main objective(s) or question(s) that the review addresses, methods, results, and implications of the findings should help readers decide whether to access the full report.29”
From PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews (2021) · cites this paper as [29]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Self-citationLiberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164 · cited 5×
“A clear description of these allows the readers to assess the applicability of the systematic review findings [11].”
BackgroundMethodInfluentialSelf-citationGRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681 · cited 1×
“Vote counting takes no account of weighting of studies according to the amount of information they contain [27].”
BackgroundSelf-citationMoher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c869 · Cited by 8,883 · cited 1×
“We developed this document using the template for the PRISMA Statement [11], which in turn was based on the methods of the CONSORT Group [14,15].”
MethodSelf-citationAssessing the quality of controlled clinical trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · BMJ · doi:10.1136/bmj.323.7303.42 · Cited by 3,309 · cited 1×
“Many tools exist for assessing the overall risk of bias in included studies, including scales, checklists and individual components [23].”
Self-citationPharmaceutical industry sponsorship and research outcome and quality: systematic review
Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003) · BMJ · doi:10.1136/bmj.326.7400.1167 · Cited by 2,147 · cited 1×
“Explanation: Studies of the relationship between pharmaceutical company funding and results of clinical trials have shown that sponsored studies are more likely to have outcomes favouring the sponsor [29,30].”
BackgroundConsensus development methods, and their use in clinical guideline development.
Murphy, Black, Lamping, McKee, Sanderson, Askham, & Marteau (1998) · Health Technology Assessment · doi:10.3310/hta2030 · Cited by 2,051 · cited 1×
“In preparation for a consensus meeting, we used a modified Delphi consensus survey method [13] to select and reduce the”
MethodChan, A.-W., Hróbjartsson, A., Haahr, M. T., Gøtzsche, P. C., & Altman, D. G. (2004) · JAMA · doi:10.1001/jama.291.20.2457 · Cited by 1,845 · cited 1×
“For randomised trials, common components include: appropriate generation of the allocation sequence [24], concealment of the allocation sequence [20], blinding of participant and health care providers, blinding of outcome assessors [22], assessment of incomplete outcome data [25], and selective outcome reporting [26].”
BackgroundSelf-citationMeta-Analyses of Randomized Controlled Trials
Sacks, H. S., Berrier, J., Reitman, D., Ancona-Berk, V. A., & Chalmers, T. C. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702193160806 · Cited by 1,250
Seventy-five trials and eleven systematic reviews a day: how will we ever keep up?
Bastian, H., Glasziou, P., & Chalmers, I. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000326 · Cited by 1,188 · cited 1×
“Conversely, a large proportion of systematic reviews are published by health technology agencies in non-English speaking countries [1], many of which provide only the abstract in English.”
BackgroundSelf-citation
Research works printed but not linked: 2
- Als-Nielsen B, Gluud LL, Gluud C (2004) Methodological quality and treatment effects in randomized trials: a review of six empirical studies. 12th Cochrane Colloquium, Ottawa (Canada).
- S Hopewell, 2008, CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration, PLoS Med, 5, e20, 10.1371/journal.pmed.0050020 · DOI · Paper page
Cited by
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D. J., Horsley, T., Weeks, L., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m18-0850 · Cited by 43,565
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · Systematic Reviews · doi:10.1186/s13643-021-01626-4 · Cited by 13,874
Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., Stewart, L. A., & the PRISMA-P Group (2015) · BMJ · doi:10.1136/bmj.g7647 · Cited by 13,120
Page, M. J., Moher, D., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n160 · Cited by 13,262
Metadata
- Authors
- Beller, E. M., Glasziou, P. P., Altman, D. G., Hopewell, S., Bastian, H., Chalmers, I., Gøtzsche, P. C., Lasserson, T., Tovey, D., & for the PRISMA for Abstracts Group
- Affiliations
- Bond University (AU)
- University of Oxford (GB)
- Inserm (FR)
- National Center for Biotechnology Information (US)
- Cochrane (DK)
- Cochrane (GB)
- Corresponding author
- Beller, Elaine M.
- ORCID
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-04-09
- Volume
- 10
- Issue
- 4
- Pages
- e1001419
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC3621753
- OpenAlex
- W2012107441
- Semantic Scholar
- 5358e30b669c8cd6f36bf5e0b9abe17a20a4e0e0
- Cited by
- 706
- References
- 34
- Citations by year
- 2026: 35 · 2025: 43 · 2024: 78 · 2023: 72 · 2022: 76 · 2021: 109 · 2020: 85 · 2019: 55 · 2018: 40 · 2017: 33 · 2016: 37 · 2015: 20 · 2014: 19 · 2013: 4
- FWCI
- 5.41
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- e-publications@bond (Bond University) (submittedVersion)
- Bond University Research Portal (Bond University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health
- U.S. National Library of Medicine
- Topics
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Social Sciences › Library and Information Sciences › Academic Writing and Publishing
- Social Sciences › Library and Information Sciences › Academic Publishing and Open Access
- Keywords
- reporting guidelines, journal abstracts
- MeSH terms
- Abstracting and Indexing, Congresses as Topic, Humans, Periodicals as Topic, Review Literature as Topic, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts. https://app.cochat.ai/papers/10.1371/journal.pmed.1001419
- The paper
- Beller, E. M., Glasziou, P. P., Altman, D. G., Hopewell, S., Bastian, H., Chalmers, I., Gøtzsche, P. C., Lasserson, T., Tovey, D., & for the PRISMA for Abstracts Group. (2013). PRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts. PLoS Medicine. https://doi.org/10.1371/journal.pmed.1001419
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.